Cresence AS
Cresence AS develops new neuroregenerative drugs for neurodegenerative disorders with unmet needs
IP Type | Status | Time | Countries | Link | What protects? |
---|---|---|---|---|---|
Patent | Pending |
|
https://patentscope.wipo.int/search/en/detail.jsf?docId=EP307590752&_cid=P22-KLGSQH-92165-1 | The invention relates to a (poly)peptide having Epidermal Growth Factor (EGF)-activity or a nucleic acid encoding said (poly)peptide for use in treating or preventing a demyelinating and/or neurodegenerating disorder |
This information is confidential, do not share or copy.
You can visit their website or
Under evaluation at least till: 22nd March
KEEP REVIEWING